News Daily News Year in Review: Structural Heart in 2025 Features EARLY TAVR, Tricuspid Nuance, Mitral Gains Caitlin E. Cox December 31, 2025
News Opinion Editor's Corner TCT 2025 What’s Going to Be Hot at TCT 2025 Michael O'Riordan October 09, 2025
News Conference News ESC 2025 ESC/EACTS Release New Valvular Heart Disease Guidelines Yael L. Maxwell September 03, 2025
News Conference News ACC 2025 By 2 Years, Tricuspid TEER Reduces Hospitalizations for HF: TRILUMINATE Michael O'Riordan March 31, 2025
News Daily News CMS Agrees to Reimburse Transcatheter Tricuspid Valve Replacement Todd Neale March 20, 2025
News Conference News THT 2025 Questioning the KCCQ: Experts Debate Its Validity as QoL Metric Todd Neale February 19, 2025
News Conference News TCT 2024 TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation Michael O'Riordan October 30, 2024
News Conference News ESC 2024 Tri.Fr Trial Affirms Quality-of-Life Impact of Tricuspid TEER Todd Neale August 31, 2024
News Daily News STS Releases New Risk-Prediction Tools for Emerging Surgical Scenarios Yael L. Maxwell May 01, 2024
News Daily News First-Ever Performance, Quality Metrics Created for Valvular and Structural Disease Michael O'Riordan March 20, 2024
News Conference News THT 2024 Debating the Role of T-TEER in the Sickest Patients Michael O'Riordan March 05, 2024
News Daily News FDA Panel Takes a Positive View of TriClip in Tricuspid Regurgitation Michael O'Riordan February 13, 2024
News Daily News FDA Approves First Transcatheter Tricuspid Valve Replacement Device L.A. McKeown February 02, 2024
News Daily News US and European Valvular Guidelines Mostly Concordant, Analysis Finds L.A. McKeown August 21, 2023
News Conference News THT 2023 Higher Gradient After Tricuspid TEER Not Harmful at 1 Year: TriValve Registry Caitlin E. Cox March 21, 2023
News Daily News Left-Sided Bioprosthetic Valves Often Dysfunctional in Pregnant Women L.A. McKeown November 21, 2022
News Daily News Frailty Before Cardiac Surgery Common, Linked to Adverse Outcomes Michael O'Riordan September 13, 2022